
èŠã ããªãã»ãŠã«ãããã¡ã€ã¶ãŒç€Ÿã®ææžããæããã«ãªã£ãããŸããšãããäºå®ã«ã€ããŠèªã
å èšäºã¯ãã¡ããã/Click here to read the original article.
ããã¡ã€ã¶ãŒã»ããŒããŒãã®èè ãããªãã»ãŠã«ããä»é±ã® ãDefender In-Depth ãã«ç»å ŽïŒ ããã¡ã€ã¶ãŒè£œè¬ã®äººé¡ã«å¯Ÿããç¯çœªã ã®èè ããªãã»ãŠã«ãããä»é±ã® ãDefender In-Depthãã«åå ããé ãããæ»ã人éã®çæ®ã«å¯Ÿããããã£ãšãããã㪠ãäžå¯éçãªå®³ãªã©ããã®ææžãæããã«ããããšã«ã€ããŠè°è«ããã
ãã€ãªãŒã¯ã©ãŠãã®CEOãããªãã»ãŠã«ãã«ããã°ãäœåäžããŒãžã«ãåã¶ãã¡ã€ã¶ãŒãšãã€ãªã³ããã¯ã®COVID-19ã¯ã¯ãã³ã«é¢ãããã¡ã€ã¶ãŒã®å éšææžãããæ»äº¡äŸãéç¯€ãªæå®³äºè±¡ãçæ®å»çãžã®äžå¯éçãªå®³ãæããã«ãªã£ããšããã
The Pfizer Papers ïŒ ããã¡ã€ã¶ãŒè£œè¬ã®äººé¡ã«å¯Ÿããç¯çœªãã®èè ã§ãããŠã«ãæ°ã¯ãä»é±ã® ãDefender In-Depth ãã«åå ããææžãšãããæããã«ããããšã«ã€ããŠè°è«ããã
圌女ã¯ã45äžããŒãžã«åã¶ãã¡ã€ã¶ãŒç€Ÿã®ææžã¯ãå瀟ãšå ¬è¡è¡çæ©é¢ããã¯ã¯ãã³ãå¹ããªãããšã確å®ã«ç¥ã£ãŠãããããšã瀺ããé£éŠæ¿åºãšãã¡ã€ã¶ãŒç€Ÿããããé èœããããšããããšãä¿ãããšè¿°ã¹ãã
ãFDAïŒã¢ã¡ãªã«é£åå»è¬åå±ïŒã¯ããããã®ææžã75幎éé ããŠããããè£å€æã«æ±ããã®ã§ãããšãŠã«ãã¯èšããã圌ãã¯ãæ¥ã®ç®ãèŠãåã«ç§ãã¡å šå¡ãæ»ã¬ããšãæãã§ããã®ã§ããã
é£éŠè£å€æã¯ãå ¬è¡è¡çãšéææ§ã®ããã®å»çå°éå®¶ã«ãã蚎èšã®æåãåããŠãææžã®å ¬éãåœããã
ã¡ãã£ã¢ããŸãããã®ææžãšã¯ã¯ãã³ã®å±éºæ§ãåœæ°ããé ãã®ã«è²¢ç®ããããã¬ã¬ã·ãŒã»ã¡ãã£ã¢ãä»äºãããŠããã°ããã®ãããªããšã¯èµ·ãããªãã£ãã§ãããããšãŠã«ãã¯èªã£ãã
圌ãã¯å€§èŠæš¡ãªæ®ºå·ãè¡ã£ãŠããããšãç¥ã£ãŠãã
ãŠã«ãã«ããã°ã倧æã¡ãã£ã¢ã®ãªãœãŒã¹ãå©çšããããšãªãã圌女ãšãã€ãªãŒã¯ã©ãŠãã®ããŒã ã¯ãææžãè§£ãã»ããåæããäžã§å°é£ãªæŠãã«çŽé¢ãããšããã
ããããã®ææžã¯éåžžã«éãå€ããå°éçãªè¡šçŸãå€ããããã©ã®ãžã£ãŒããªã¹ãã«ãšã£ãŠãçè§£ã説æããã®ãéåžžã«å°é£ã§ããããšãŠã«ãã¯èªã£ãã解決çã¯ããã©ã³ãã£ã¢ã®ç§åŠè
ãåããææžã®èŠçŽããæäŒã£ãŠãããããšã ã£ãã
ããã©ã³ãã£ã¢ã®å°éå®¶ãåéãããšãã......é©ãããšã«ã3,250人ã®å»åž«ãç§åŠè
ããè¿äºããã£ãããšãŠã«ãã¯èªã£ãã
ãŠã«ãã¯ããã¡ã€ã¶ãŒãšå
¬è¡è¡çæ©é¢ãèšåºè©ŠéšããŒã¿ãæäœãã詊éšåå è
ã®æ»äº¡å ±åãé
ãããå®å
šæ§ç®æšãéæããã¯ã¯ãã³ã ãå®å
šã§å¹æç ãã§ãããšäž»åŒµããããšãææžããæããã«ãªã£ããšè¿°ã¹ãã
ã圌ãããã䞻匵ããããšãã§ããå¯äžã®æ¹æ³ã¯ãCOVIDã§æ»äº¡ãã8人ã®ã¯ã¯ãã³æ¥çš®è
ã®éºäœãé ããCDCïŒçŸç
管çäºé²ã»ã³ã¿ãŒïŒãžã®æ»äº¡å ±åãéæ³ã«é
ãããããšã§ããããšãŠã«ãã¯èªã£ãã
æ»äº¡äŸã®é èœã¯ããã¡ã€ã¶ãŒç€Ÿããã®äºé²æ¥çš®ãå±éºãªãã®ã§ããããšããéåžžã«æ©ã段éããããã€ãŸãäºé²æ¥çš®éå§åŸ3ã¶æä»¥å
ã«ç¥ã£ãŠããããšã瀺ãäžã€ã®å
åã«éããªãããšãŠã«ãæ°ã¯èšãã
ãŠã«ãã¯èšãïŒ
ã圌ãã¯3ã¶æä»¥å
ã«1,223äººãæ»äº¡ããå¯äœçšãããããšãç¥ã£ãŠããŸãããéç¯€ãªæå®³äºè±¡ã43,000人ãåèšã§130,000人以äžã«èµ·ãã£ãŠããŸãã圌ãã¯å€§èŠæš¡ã«äººã
ãæ®ºå·ããŠããããšãç¥ã£ãŠããã
ãŠã«ãã«ããã°ãã¯ã¯ãã³ã®æå®³äºè±¡ã¯ãã°ãã° ãç Žæ» ç ãã§ããããæãããè¡æ ãèºè¡æ ......å¿èçãå¿ççãããããçš®é¡ã®å¿èé害ãå€§èŠæš¡ãªç¥çµé害ããŠããããèªç¥çããã«éº»çºãã®ã©ã³ã»ãã¬ãŒçå矀ãã¿ãŒããã......èèé害ãè èé害ããªã©ãå«ãŸããŠãããšããã
ãŠã«ãã«ããã°ãæãå€ãå ±åãããŠããæå®³äºè±¡ã¯çèçãšé¢ç¯çã§ãããšããããå€ãã®äººãä»ãæ°åãæªãããã®çç±ããããããå»åž«ããã®çç±ãããããªãã®ã§ããããã¡ã€ã¶ãŒã¯ãã®çç±ãç¥ã£ãŠããã®ã§ã
ãã¡ã€ã¶ãŒç€Ÿã¯ãã¯ã¯ãã³ãè質ããç²åãš ã¹ãã€ã¯ã»ãããã€ã³ããããŠç³æ²¹ã®å¯ç£ç©ã§ããããªãšãã¬ã³ã°ãªã³ãŒã«ãçç©åŠçã«ååžãããããšãç¥ã£ãŠããã
ãä»ãå€ãã®äººãé¢ç¯çã«ãªã£ãããèã®äººå·¥é¢ç¯çœ®æè¡ãè©ã®äººå·¥é¢ç¯çœ®æè¡ãå¿ èŠãšããŠããŸãããã¡ã€ã¶ãŒç€Ÿã¯ã泚å°ãççãèµ·ããããšãé¢ç¯çãççãèµ·ããçç¶ã§ããããšãç¥ã£ãŠããã®ã§ãããšãŠã«ãã¯ä»ãå ããã
ãæ³åãçµ¶ãã8ããŒãžã
ãŠã«ãã«ãšã£ãŠããã¡ã€ã¶ãŒç€Ÿã®ææžããæããã«ãªã£ãæãé倧ãªäºå®ã¯ãã¯ã¯ãã³ã人éã®çæ®ã«äžãã圱é¿ã«é¢ä¿ããŠããã
ããã¡ã€ã¶ãŒç€Ÿã®è«æã®ç®çã¯ã»ã»ã»äººéã®çæ®ãæ§ã ãªæ¹æ³ã§ç Žå£ããããšã§ãããšãŠã«ãã¯èšãããè質ããç²åã¯äººäœã®ããããèãééããããã«èšèšãããŠãããããã¯ãã°ã§ã¯ãªããç¹åŸŽãªã®ã§ãããšãŠã«ãã¯èšãã
ãŠã«ãã¯ã15,000人ã®å¥³æ§ãæ¯æ¥åºè¡ãã10,000人ã®å¥³æ§ã¯æã«2åççãããã7,500人ã®å¥³æ§ã¯ãŸã£ããççããªãã£ãã
åŠå©Šãå¯äœçšãçµéšããããã¡ã€ã¶ãŒç€Ÿã¯èšåºè©Šéšã«åå ãã234人ã®åŠå©Šã®èšé²ãçŽå€±ãããããããèšé²ãæ®ã£ãŠãã36人ã®åŠå©Šã«ã€ããŠã¯ãã80ïŒ ä»¥äžãèµ€ã¡ããã倱ã£ãŠããŸãããšãŠã«ãã¯èšã£ãã
ãŠã«ãæ°ã«ããã°ãæå®³äºè±¡ã®62ïŒ ã女æ§ã§ããã®ãã¡ã®16ïŒ ãçæ®é害ã§ãã£ãã®ã«å¯Ÿããç·æ§ã¯0.2ïŒ ã§ãã£ããææžã«ã¯ã女æ§ãèå ãžã®ãªã¹ã¯ããããšããŠãã¯ã¯ãã³æ¥çš®ãåããç·æ§ã«åŠåš å¯èœå¹Žéœ¢ã®å¥³æ§ãšã®æ§äº€ãé¿ããããå§ãããäžç©ãªéšåããå«ãŸããŠããã
ãŠã«ãã«ããã°ããã¡ã€ã¶ãŒç€Ÿã®8ããŒãžã«åã¶ææžãåŠåš ãšæä¹³ã«é¢ããå ±åæžãã«ã¯ã乳幌å ã«æ·±å»ãªå·å®³ãæ»äº¡äŸãããããšãèšãããŠãããšããã
ãæ³åãçµ¶ãã8ããŒãžã§ããããã®ææžã«ã¯èå ã§æ»äº¡ããèµ€ã¡ããã2人ããŠããã¡ã€ã¶ãŒç€Ÿã¯ãã®æ»äº¡ã¯æ¯èŠªãã¯ã¯ãã³ã«ãããããããã ãšçµè«ã¥ããŠããŸãããŸããã¯ã¯ãã³ãæ¥çš®ããæ¯èŠªã«æä¹³ããŠããèµ€ã¡ãããéç ã«ãªã£ãŠããããšã瀺ãã°ã©ããããã
人ã ã®ç®èŠãã¯éã«åã£ã
ãŠã«ãã¯ã倧æè£œè¬äŒç€Ÿã ãã«ïŒã¡ãªã³ãã»ã²ã€ã財å£ã®ãããªããã¯ã¯ãã³ãžã®ãããããå æãã ãããã«ã¡ãã£ã¢ã« ãå·šé¡ã®è³é ããæäŸããçµç¹ããè³éæäŸãåããŠãããããã¬ã¬ã·ãŒã¡ãã£ã¢ã¯ãããã®æŽé²ãç¡èŠãããšè¿°ã¹ãã
ããããã®ææžã¯ã¯ã¯ãã³ãžã®ãããããå æãããã®ã§ã¯ãªããã¯ã¯ãã³ãžã®ãããããçã¿åºããã®ã§ãããããããã¡ãã£ã¢ã¯éãåãåãããããã®å·šå€§ç¯çœªã«å æ ãããŠããããããã¡ã€ã¶ãŒç€Ÿã®ææžã®ãããªæŽé²ãç¡èŠããŠããã
ãããã人ã ã®æèã¯é«ãŸã£ãŠããããŠã«ãã¯èšãïŒ
ã圌ãã¯ç§ãã¡ãäžåŠåããããšãããç§ãã¡ãç¡ååããæ®ºãããšããããããŠæåããªãã£ãã人å£ãæ·æ±°ãã西æŽãæ·æ±°ãããšãã圌ãã®å倧ãªèšç»ã¯ãŸã æåããŠããªãã人ã ãç®ãèŠãŸãã®ã«éã«åã£ãã®ã ãã
ãŠã«ãã¯ãåœŒå¥³ã®æ¬ã«ã¯ ããŸããšãããã㪠ãäºå®ãæžãããŠãããããåœãæã ãæ¬ã§ãããããšèªã£ãã
圌女ã¯ãæ»æã¯çµãã£ãŠããªããšèªã£ãããã°ããŒããªã¹ãã¯æ¢ãŸããªããããããç§ãã¡å šå¡ãæµæããã°ãããšãç§ãã¡ãããŸãåããªããšæã£ãŠããŠããç§ãã¡ã¯ãšãŠãåãããããšããããã